See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rebif
Generic Name: Interferon beta-1a SubQ injection
What is Interferon beta-1a SubQ injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
See more information, including instructions, precautions, side effects, and interactions.
1237 patients in the community are taking or have taken Interferon beta-1a SubQ injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 1027 | 83% |
| Other | 43 | 3% |
| Stiffness/spasticity | 14 | 1% |
| Fatigue | 13 | 1% |
| General health | 12 | <1% |
| disease-related symptoms | 10 | <1% |
| Don't know | 5 | <1% |
| Support another treatment | 2 | <1% |
| Pain | 2 | <1% |
| Anxiety | 1 | <1% |
| Depression | 1 | <1% |
| Balance problems | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Emotional lability | 1 | <1% |
| Weakness/slowness (asthenia) | 1 | <1% |
| Treat my MSA | 1 | <1% |
| Cognition | 1 | <1% |
| Vision | 1 | <1% |
| Sensation | 1 | <1% |
| Mobility | 1 | <1% |
| MS | 1 | <1% |
Based on the patients currently taking Interferon beta-1a SubQ injection.
Top 10 (Show all)
All (Show Top 10)
| 0 - As needed | 0 - Daily | 0 mcg Daily | 0 mg Daily | 0 - Monthly | 0 - Weekly | 0 mcg Weekly | 0 mg Weekly | 0 Weekly | 0 mcg | 0 mg | 0 | 0 mcg | 0.44 mg As needed | 22 mcg As needed | 44 mcg All the time (24/7) | 44 mcg As needed | 44 mg As needed | 44 mcg Daily | 132 mcg Weekly | 0.14 mcg | 0.44 mg Weekly | 0.5 mcg Weekly | 0.5 mg Weekly | 0.22 mg | 0.25 mcg | 0.25 mg | 1 g Weekly | 1 Weekly | 0.3 mcg | 0.3 mg | 1.1 Weekly | 0.44 mcg | 0.5 mcg | 0.44 mcg | 0.44 mg | 0.44 | 0.5 mcg | 0.5 mg | 0.3 mcg Daily | 0.3 mg Daily | 0.8 mcg | 0.75 mg | 1 mcg | 3 mcg Weekly | 3 mg Weekly | 3 Weekly | 1 mcg | 1 mg | 1 | 4.4 mcg Weekly | 2.2 mcg | 1 mL Daily | 8.8 mcg Weekly | 3 mcg | 3 mcg | 3 mg | 4.4 mcg | 15 mcg Weekly | 20 mg Weekly | 3 mg Daily | 22 mcg Weekly | 22 mg Weekly | 24 mcg Weekly | 26.4 mcg Weekly | 10 mcg | 30 mcg Weekly | 30 mg Weekly | 132 mcg Monthly | 8.8 mg | 33 mg Weekly | 10 | 12 mcg | 40 mcg Weekly | 40.5 mcg Weekly | 44 mcg Weekly | 44 mg Weekly | 44 Weekly | 60 mg Weekly | 8.8 mcg As needed | 22 mcg Daily | 22 mcg | 66 mcg Weekly | 66 mg Weekly | 10 mg Daily | 20 mcg | 20 mg | 22 mcg | 22 mg | 22 | 25 mg | 88 mcg Weekly | 30 mcg | 33 mcg | 30 mcg Daily | 30 mcg | 112 mcg Weekly | 40 mcg | 120 mg Weekly | 528 mcg Monthly | 126 mcg Weekly | 44 mcg As needed | 44 mcg Daily | 44 mcg Weekly | 44 mcg | 132 mcg Daily | 132 mcg Weekly | 132 mg Weekly | 132 Weekly | 134 mcg Weekly | 40 mcg | 40 | 41 mcg | 43 mg | 152 mg Weekly | 22 mcg Daily | 44 mcg As needed | 44 mcg Daily | 44 g | 44 mcg | 44 mg | 44 | 176 mcg Weekly | 30 mcg Daily | 100 mcg | 300 Weekly | 44 mg All the time (24/7) | 44 mcg As needed | 44 mcg Daily | 44 mcg Weekly | 132 mcg Weekly | 132 mcg | 138 mcg | 144 mcg | 125 | 66 mcg Weekly | 132 mcg Weekly | 132 mcg | 144 mg | 100 mcg Daily | 200 mcg | 200 mg | 132 mcg Daily | 132 mcg Weekly | 132 mg Weekly | 321 mcg | 300 mg | 200 g Daily | 250 mcg Daily | 500 mcg | 300 other Daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
1
|
1
|
4
|
6
|
5
|
1
|
15
|
2
|
21
|
26
|
1
|
1
|
2
|
10
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
8
|
1
|
3
|
3
|
1
|
3
|
3
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
2
|
3
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
5
|
4
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
58
|
18
|
2
|
1
|
1
|
1
|
9
|
11
|
2
|
1
|
1
|
1
|
5
|
5
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
1
|
2
|
5
|
1
|
102
|
1
|
99
|
16
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
11
|
1
|
4
|
2
|
44
|
83
|
21
|
1
|
1
|
1
|
1
|
1
|
3
|
48
|
1
|
10
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
3
|
2
|
1
|
9
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 196 | 55% | |
| Did not seem to work | 108 | 30% | |
| Doctor's advice | 76 | 21% | |
| Other | 61 | 17% | |
| Personal research | 16 | 4% | |
| Not indicated | 13 | 4% | |
| Expense | 12 | 3% | |
| Course of treatment ended | 6 | 2% |
Results from 102 patient evaluations. See the overall results and all individual evaluations.
| Major | 14% | 13 |
|---|---|---|
| Moderate | 12% | 11 |
| Slight | 10% | 9 |
| None | 13% | 12 |
| Can't tell | 52% | 49 |
Slow my MS progress
| Severe | 16% | 16 |
|---|---|---|
| Moderate | 39% | 40 |
| Mild | 34% | 35 |
| None | 11% | 11 |
Top reported side-effects include: Muscle ache, whole body, injection site redness, Chills/fever
Summary results are based on 102 individual responses. For more information, see overall results for Adherence, Burden and Cost.